Personalized Treatment of Glioblastoma: Current State and Future Perspective

Glioblastoma (GBM) is the most aggressive glial tumor of the central nervous system. Despite intense scientific efforts, patients diagnosed with GBM and treated with the current standard of care have a median survival of only 15 months. Patients are initially treated by a neurosurgeon with the goal...

Descripción completa

Detalles Bibliográficos
Autores principales: Rončević, Alen, Koruga, Nenad, Soldo Koruga, Anamarija, Rončević, Robert, Rotim, Tatjana, Šimundić, Tihana, Kretić, Domagoj, Perić, Marija, Turk, Tajana, Štimac, Damir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296009/
https://www.ncbi.nlm.nih.gov/pubmed/37371674
http://dx.doi.org/10.3390/biomedicines11061579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296009/
https://www.ncbi.nlm.nih.gov/pubmed/37371674
http://dx.doi.org/10.3390/biomedicines11061579

Ejemplares similares